Friday, May 1, 2026

HK inno.N partners with Atomatrix to co-develop AI-based next-generation obesity drug

HK inno.N partners with Atomatrix to develop AI-driven obesity treatments, focusing on novel small-molecule candidates.

Thomas Jefferson, Architect of American Independence

Thomas Jefferson, a key figure in American independence and democracy, authored the Declaration of Independence and promoted civil liberties.

North Korea’s Civilian Abduction Crisis: 10 Nations Can Be a Tool for US Diplomacy

Experts urge global action to address North Korea's civilian abductions, emphasizing international condemnation and cooperation for resolution.

Tag: cancer

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Coreline Soft Secures Major AI Contract with Italy’s National Cancer Center for Lung Cancer Early Detection

Coreline Soft renews its contract for AVIEW LCS Plus with Italy's National Cancer Center, enhancing early lung cancer diagnosis via AI.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Revolutionary Immune Therapy for Colon Cancer: How MAFB Protein Manipulation Enhances Treatment Response

Korea University researchers have developed a new colorectal cancer treatment strategy by regulating tumor-associated macrophages to enhance immune response.

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Proton Therapy for Liver Cancer: Revolutionary Results from Samsung Medical Center

Samsung Medical Center's proton therapy shows high effectiveness for liver cancer, offering hope for patients unsuitable for standard treatments.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

2026 Hyundai Boulder: The Ultimate Off-Road Pickup Truck Concept Revealed!

Hyundai unveils the Boulder, an off-road concept vehicle, at the NY Auto Show, showcasing its commitment to U.S. mid-size pickup market.

Samsung Medical Center Achieves ICHOM Certification: A New Era for Patient-Centered Cancer Care in Korea

Samsung Medical Center's Cancer Hospital is the first in South Korea to receive ICHOM certification for patient-centered care in breast cancer.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.